Health
Encouraging results from trial of inhaled drug to help COVID-19 patients – Mirage News
The University of Southampton and drug-development-company Synairgen plc have announced positive results from clinical trials of a drug (SNG001 – inhaled…
The University of Southampton and drug-development-company Synairgen plc have announced positive results from clinical trials of a drug (SNG001 – inhaled formulation of interferon beta) that may prevent worsening of COVID-19 in those most at risk.
The odds of developing severe disease (e.g. requiring ventilation or resulting in death) during the treatment period (day 1 to day 16) were significantly reduced by 79 per cent for patients receiving SNG001, compared to patients who received placebo.
…
-
General21 hours agoThree NT residents charged with fraud over alleged $71 million Defence contract scheme
-
General18 hours agoVote counting begins for Townsville mayoral by-election
-
Noosa News24 hours agoQueensland GPs to be able to diagnose adults with attention deficit hyperactivity disorder from December 1
-
General21 hours agoPolice to patrol Melbourne shopping centres in 90-day youth crime prevention trial